Neo Ivy Capital Management’s Privia Health PRVA Stock Holding History

Neo Ivy Capital Management’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-67,526	Closed	-$1.55M	–	510
2025 Q2	$1.55M	Buy	+67,526	New	+$1.56M	0.5%	71
2025 Q1	–	Sell	-6,540	Closed	-$127K	–	399
2024 Q4	$127K	Buy	6,540 +2,936	+81%	+$58.2K	0.03%	229
2024 Q3	$66K	Buy	+3,604	New	+$68.8K	0.02%	242
2023 Q4	$9K	Buy	+372	New	+$8.33K	0.02%	239
2023 Q3	–	Sell	-2,040	Closed	-$53K	–	431
2023 Q2	$53K	Buy	+2,040	New	+$53.9K	0.03%	250
2022 Q4	$508K	Buy	22,356 +21,743	+3,547%	+$605K	0.34%	120
2022 Q3	$21K	Buy	+613	New	+$22.7K	0.06%	292
2022 Q2	–	Sell	-7,346	Closed	-$196K	–	574
2022 Q1	$196K	Buy	+7,346	New	+$173K	0.18%	202

Other funds holding PRVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neo Ivy Capital Management's PRVA Position: Q3 2025 in Review

Neo Ivy Capital Management sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 67,526 shares — an estimated $1.55M sold.

Neo Ivy Capital Management first reported a position in PRVA in Q1 2022 and held it in 8 quarters. The position peaked at $1.55M in Q2 2025. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

Neo Ivy Capital Management reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 67,526 Privia Health shares in Q3 2025, an estimated $1.55M.
Neo Ivy Capital Management first reported a position in Privia Health in Q1 2022 and held it in 8 quarters.
Neo Ivy Capital Management's Privia Health position peaked at $1.55M in Q2 2025.
259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Neo Ivy Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.